VIGAMOX is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Moxifloxacin Hydrochloride.
| Product ID | 0065-4013_0781161f-3088-4721-ad72-c7daeb88fc58 |
| NDC | 0065-4013 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VIGAMOX |
| Generic Name | Moxifloxacin Hydrochloride |
| Dosage Form | Solution/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2003-05-07 |
| Marketing End Date | 2022-07-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021598 |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | MOXIFLOXACIN HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/mL |
| Pharm Classes | Quinolone Antimicrobial [EPC], Quinolones [CS] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2003-05-07 |
| Marketing End Date | 2022-07-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021598 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2003-05-07 |
| Marketing Category | NDA |
| Application Number | NDA021598 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2003-05-07 |
| Marketing Category | NDA |
| Application Number | NDA021598 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2003-05-07 |
| Marketing End Date | 2011-07-14 |
| Ingredient | Strength |
|---|---|
| MOXIFLOXACIN HYDROCHLORIDE | 5 mg/mL |
| SPL SET ID: | 0e6ab6ba-5eeb-4faf-ba80-4bf21a74228a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0065-4013 | VIGAMOX | moxifloxacin hydrochloride |
| 0078-0939 | VIGAMOX | moxifloxacin hydrochloride |
| 21695-968 | VIGAMOX | moxifloxacin hydrochloride |
| 50090-0859 | VIGAMOX | moxifloxacin hydrochloride |
| 70518-2043 | VIGAMOX | VIGAMOX |
| 0085-1733 | Avelox | moxifloxacin hydrochloride |
| 0085-1737 | Avelox | moxifloxacin hydrochloride |
| 0065-0006 | MOXEZA | moxifloxacin hydrochloride |
| 48792-7823 | Moxifloxacin | moxifloxacin hydrochloride |
| 0093-7387 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
| 0832-1410 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
| 13668-201 | moxifloxacin hydrochloride | moxifloxacin hydrochloride |
| 40032-034 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
| 43063-580 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride |
| 43063-585 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride |
| 47781-268 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride |
| 50090-4058 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
| 50090-4100 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
| 0781-7135 | Moxifloxacin Ophthalmic Solution | moxifloxacin hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VIGAMOX 78203609 2924187 Live/Registered |
NOVARTIS AG 2003-01-15 |
![]() VIGAMOX 77770376 3751687 Live/Registered |
NOVARTIS AG 2009-06-29 |